Kevin Charles Gorman Neurocrine Biosciences Inc (NBIX) insider trading activity

Kevin Charles Gorman is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 514,596 shares of NBIX, which is worth approximately $66.3 Million. The most recent transaction as insider was on Feb 08, 2022, when has been sold 2,274 shares (Common Stock) at a price of $79.49 per share, resulting in proceeds of $180,760. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 515K

1.83% 3M change

0% 12M change

Total Value Held $66.3 Million

KEVIN CHARLES GORMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2022	SELL Open market or private sale	$180,760 $79.49 p/Share	2,274 Reduced 0.49%	462,844 Common Stock
Feb 07 2022	SELL Open market or private sale	$703,942 $80.82 p/Share	8,710 Reduced 1.86%	460,801 Common Stock
Feb 08 2021	SELL Open market or private sale	$1,221,906 $116.75 p/Share	10,466 Reduced 2.26%	452,972 Common Stock
Feb 05 2021	SELL Open market or private sale	$276,496 $114.16 p/Share	2,422 Reduced 0.54%	443,249 Common Stock
Jan 08 2021	SELL Open market or private sale	$33,975,315 $110.22 p/Share	308,250 Reduced 41.14%	441,071 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	$2,669,445 $8.66 p/Share	308,250 Added 33.72%	605,872 Common Stock
Nov 12 2020	SELL Open market or private sale	$307,744 $90.78 p/Share	3,390 Reduced 0.76%	441,071 Common Stock

Also insider at

XNCR

Xencor Inc Healthcare

Director

KCG